Status:

COMPLETED

Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema)

Lead Sponsor:

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Collaborating Sponsors:

Pfizer

Conditions:

Proliferative Diabetic Retinopathy

Diabetic Macular Edema

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Patients with proliferative diabetic retinopathy or clinically significant diabetic macular edema requiring surgical intervention will receive a pre-operative injection of Macugen. An initial, pre-inj...

Detailed Description

Diabetes is one of the leading causes of blindness in North America. Diabetic retinopathy (PDR) is characterized by disruption of the normal microvascular circulation in the retina and results in the ...

Eligibility Criteria

Inclusion

  • 18 years or older
  • Type 1 or 2 diabetes
  • patients requiring surgical intervention for complications of proliferative diabetic retinopathy with vitreous hemorrhage or traction retinal detachment or clinically significant macular edema
  • women postmenopausal for 12 months before the study, surgically sterile, or not pregnant and on effective contraception.

Exclusion

  • previous retinal vein occlusion.
  • any intraocular surgery within the previous 12 months.
  • myopia of \> or = to 8 diopters.
  • active ocular or periocular infection
  • treatment with an investigational agent for any condition 60 days prior to enrollment.
  • evidence of severe cardiac disease.
  • clinically significant peripheral vascular disease (previous surgery, amputation, or symptoms of claudication)
  • uncontrolled hypertension (treated systolic blood pressure \> 155 mmHg or diastolic blood pressure \> 95 mmHg)
  • stroke within the preceding 12 months.

Key Trial Info

Start Date :

October 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2008

Estimated Enrollment :

28 Patients enrolled

Trial Details

Trial ID

NCT00446381

Start Date

October 1 2006

End Date

September 1 2008

Last Update

April 19 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ivey Eye Institute, St. Joseph's Health Care Centre

London, Ontario, Canada, N6A 4G5